Fact CheckerSign in

NCT06924372Active, not recruiting

Application of Salivary Biomarkers in Risk Assessment for Oral Diseases in Children With Type 1 Diabetes

Source: ClinicalTrials.gov · Last updated 11 Apr 2025

Brief summary (registry, in English)

This research contributes to a deeper understanding of the etiopathogenesis of periodontal and other oral diseases in children with T1D. By analyzing the composition of the salivary microbiome and detecting pathogenic and opportunistic microorganisms, the study aims to develop targeted preventive strategies. The findings could lead to personalized preventive programs, improving early diagnosis and oral health management in this vulnerable population.This study hypothesizes that children with Type 1 Diabetes (T1D) will exhibit significantly different oral health parameters compared to healthy peers. Specifically: 1. Higher KEP and KEPS index values (Klein-Palmer system) indicating increased caries incidence. 2. Higher Silness and Loe plaque index and Loe and Silness gingival index, suggesting greater plaque accumulation and gingival inflammation. 3. Lower salivary buffering capacity and pH, potentially contributing to an increased risk of oral diseases. 4. A distinct microbial profile, with a greater presence of pathogenic and opportunistic bacteria. 5. A significantly higher Candida albicans count in the saliva. These findings could provide insights into the oral health challenges faced by children with T1D and guide preventive strategies. This study explores how saliva can help assess the risk of dental and gum problems in children with Type 1 Diabetes (T1D). Researchers will analyze saliva samples to identify specific markers that may indicate a higher chance of cavities, gum disease, and oral infections. The goal is to develop early detection and prevention methods to improve oral health care for children with T1D. The study will include 112 children aged 6 to 18. Half of them have Type 1 Diabetes, while the other half are healthy children of the same age and gender for comparison. All participants will be selected from the Clinic for Dentistry of Vojvodina, ensuring they are not currently sick and have not taken antibiotics in the past month. Children with other serious health conditions, fixed braces, or difficulty cooperating will not be included. Researchers will examine different factors that could affect oral health in children with T1D, including saliva acidity (pH), its ability to neutralize acids, the presence of bacteria and fungi, and the condition of teeth and gums. They expect that children with T1D will have: 1. More cavities compared to healthy children. 2. More plaque buildup on teeth and greater gum inflammation. 3. Lower saliva protection against acids, increasing the risk of dental problems. 4. A different mix of bacteria in the mouth, with more potentially harmful microbes. 5. Higher levels of the fungus Candida albicans in saliva. The findings from this study may help better understand oral health challenges in children with T1D and lead to improved prevention and treatment strategies.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
112 (estimated)
First submitted
2 Apr 2025
Start date
31 Jan 2025
Primary completion date
1 Jul 2025
Lead sponsor
University of Novi Sad
NCT number
NCT06924372

What you commit to

  • Study type: Observational
  • Planned participants: 112
  • From 31 Jan 2025 to the primary completion date, 1 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Associated diseases

Other

  • Uncooperative patient
  • Unsigned informative consent from the data subject/parent/guardian
  • Antibiotic use in the last few months
  • Subjects with orthodontic appliances

Who the study is looking for

  • Age of subjects from 6 to 18 years, both sexes, with mixed or permanent dentition present.
  • An experimental group of at least 56 subjects will be children diagnosed with DM type 1 (at least one year)
  • The control group includes at least 56 subjects, healthy children, who match the tested group in gender and age, with the absence of acute diseases.

Age in the registry: 6 years to 18 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical Faculty, University of Novi Sad
Coordinator of this site? Confirm its status
Novi SadSerbiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.